Literature DB >> 6448353

In vitro characterization of immunological responsiveness of uremic patients.

T Kunori, I Fehrman, O Ringdén, E Möller.   

Abstract

Uremic patients are thought to have deficient immune reactivity. The mechanisms for immunosuppression are not known. We have studied various in vitro immune response parameters in lymphocytes from uremic patients and from healthy controls. Using polyclonal activating substances, it was found that PHA and LPS responses were reduced in cells from the patient group compared to the control group (p < 0.05). Furthermore, MLC responsiveness using pooled stimulator cells and polyclonal antibody secretion induced by Staphylococcus aureus bacteria in vitro were reduced in the patients (p < 0.05). No differences with regard to proportions of T/B cells in blood were noted between the two groups. No correlation was found between responses of individual cells to different activating substances, with the exception of PHA and ConA. However, low responses to PHA were usually accompanied by a general low responsiveness. Patients were further subdivided into groups according to the type of dialysis treatment, peritoneal dialysis (PD) or hemodialysis (HD), and to the duration of the hemodialysis period (< and > 1 year). Patients treated with PD showed impaired T cell reactivity with loer PHA responses compared to the HD patients (p < 0.05). Between the HD groups there were no significant differences in mitogen or MLC responses. We believe that the differences between PD and HD were due to the facts that the PD patients were older and not in the same nutritional state as the HD patients.

Entities:  

Mesh:

Year:  1980        PMID: 6448353     DOI: 10.1159/000181991

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  8 in total

Review 1.  The use of vaccines in renal failure.

Authors:  D W Johnson; S J Fleming
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

2.  Impaired in vitro growth of PHA induced T lymphocyte colonies in hemodialyzed renal failure patients.

Authors:  R Ghio; E Haupt; V Pistoia; A Perata; P Minale; M Ratti; P Boccaccio
Journal:  Blut       Date:  1985-03

3.  Antibody production and antigenic specific suppression to bovine serum albumin in uremic rats.

Authors:  S Mezzano; A Pesce; T Peters; V E Pollak; R Reed; G Michael
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

4.  In vitro analysis of B lymphocyte function in uraemia.

Authors:  D Degiannis; A M Mowat; E Galloway; D Tsakiris; J D Briggs; B J Junor; D M Parrott
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

5.  Humoral inhibitors of the immune response in uremia. V. Induction of suppressor cells in vitro by uremic serum.

Authors:  J Raskova; K Raska
Journal:  Am J Pathol       Date:  1983-05       Impact factor: 4.307

6.  Impact of long-term hemodialysis on nutritional status in patients with end-stage renal failure.

Authors:  P Kaufmann; K H Smolle; J H Horina; R Zach; G J Krejs
Journal:  Clin Investig       Date:  1994-10

7.  Longitudinal SARS-CoV-2 seroconversion and functional heterogeneity in a pediatric dialysis unit.

Authors:  Jorge J Canas; Michelle C Starr; Jenaya Hooks; Samuel Arregui; Amy C Wilson; Aaron E Carroll; Vijay Saxena; Fatima Amanat; Florian Krammer; Jeffrey Fill; Andrew Schade; Antonio Chambers; Jack Schneider; Andrew L Schwaderer; David S Hains
Journal:  Kidney Int       Date:  2021-02       Impact factor: 10.612

8.  Studies on IL-2 production and T-cell colony forming unit in patients with chronic renal failure.

Authors:  S K Ha; H S Cho; H Y Lee; H S Kim; K H Choi; D S Han; B K Lee; J D Kim
Journal:  Korean J Intern Med       Date:  1993-07       Impact factor: 2.884

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.